Female Infertility: Understanding Testing Options

Female infertility affects at least 10% of women and is defined as the inability to achieve pregnancy after 12 months of regular, unprotected intercourse for women under 35, or after 6 months for women over 35. While the experience can feel isolating, understanding the underlying causes and available testing options provides clarity and a foundation for informed decision-making.

Approximately 15% of couples worldwide experience infertility, with female factors accounting for roughly 50% of cases, male factors for about 40%, and combined or unexplained causes making up the remainder. Many couples ultimately conceive without medical treatment. Female infertility can stem from hormonal imbalances affecting ovulation, structural abnormalities in the reproductive tract, age-related decline in egg quality and quantity, thyroid dysfunction, and other medical conditions. Comprehensive testing helps identify which of these factors may be involved and guides appropriate treatment decisions.

Ovulation disorders are the most common cause of female infertility, driven by problems in the hormonal regulation carried out by the hypothalamus, pituitary gland, or ovaries. Polycystic ovary syndrome (PCOS) is the single most frequent cause, producing hormone imbalances that disrupt regular ovulation. Diminished ovarian reserve (DOR), in which fewer eggs remain in the ovaries than expected for a given age, can result from congenital factors, medical treatments, surgery, or unexplained causes. Impaired signaling from the hypothalamus or pituitary gland can also reduce ovarian function.

Damaged or blocked fallopian tubes can prevent sperm from reaching the egg or block a fertilized egg from traveling to the uterus. Causes include pelvic inflammatory disease from sexually transmitted infections, prior abdominal or pelvic surgery, and endometriosis. Elevated prolactin levels can suppress estrogen production and interfere with fertility. Thyroid dysfunction has long been recognized as a contributor to reproductive difficulties. Age is a significant independent factor, as fertility naturally declines over time, with the decline accelerating after age 35.

General guidance recommends trying to conceive for at least one year before pursuing testing for women under 35. For women between 35 and 40, discussing concerns with a healthcare provider after six months of trying is appropriate. For women over 40, earlier evaluation may be recommended. Testing should also be considered sooner when there are known fertility risk factors, irregular or painful periods, a history of pelvic inflammatory disease, recurrent miscarriages, or prior cancer treatment.

Hormone testing can provide valuable insight into ovarian function, ovulation patterns, and potential underlying causes. Some fertility hormones can be tested at any point in the menstrual cycle, while others are most informative when drawn on specific cycle days. Women experiencing irregular cycles, unexplained weight changes, or excessive hair growth may also benefit from evaluation, as these symptoms can indicate conditions like PCOS or thyroid dysfunction that affect reproductive health.

Fertility test results illuminate different aspects of reproductive function and should be interpreted by a healthcare provider within the context of individual circumstances. FSH levels, typically tested on cycle day 3, assess ovarian reserve; normal values range from approximately 3 to 10 mIU/mL, with higher levels suggesting diminished reserve. AMH reflects the remaining egg supply, with typical ranges of 1.0 to 4.0 ng/mL; lower values may indicate reduced egg quantity, while very high values can suggest PCOS.

Progesterone drawn approximately one week after ovulation can confirm whether ovulation occurred, with levels around 10 ng/mL indicating successful ovulation. Elevated prolactin can suppress ovulation and cause fertility problems. TSH levels, even within the normal reference range, may be relevant: some studies suggest that women with unexplained infertility tend to have higher TSH levels compared to fertile controls. Abnormal results do not automatically mean permanent infertility; many hormonal imbalances are treatable, and many women with these findings go on to conceive with appropriate management.

While some causes of female infertility are not preventable, certain lifestyle factors can support reproductive health and optimize fertility potential. Maintaining a healthy weight through balanced nutrition and regular exercise helps regulate hormones and improve ovulation patterns. Stress management through relaxation techniques, adequate sleep, and mindfulness practices may also benefit reproductive function, as chronic stress can disrupt hormone production and menstrual regularity.

Avoiding smoking and limiting alcohol consumption are important, as both can negatively affect egg quality and fertility. Taking prenatal vitamins with folic acid, maintaining adequate vitamin D levels, and ensuring sufficient intake of iron and omega-3 fatty acids may support reproductive health. However, lifestyle modifications alone may not address underlying medical causes of infertility, and professional medical evaluation remains essential for accurate diagnosis and effective treatment planning.